Published on
September 2, 2025
- 20:00 GMT
Solaris Endovascular Exceeds Enrollment Milestone for DEScover Trial; Interim Data to be Shared at Vascular Conferences
80% of Patients Now Enrolled in Pioneering Drug-Eluting Covered Stent Graft Study NEW ORLEANS, LA, UNITED STATES, September 2, 2025 /EINPresswire.com/ -- Solaris Endovascular, Inc., a growth-stage U.S.-based medical device company specializing …
Distribution channels:
Banking, Finance & Investment Industry, Business & Economy
...
